Craig A Williamson1, Ivan Co2, Aditya S Pandey3, B Gregory Thompson3, Venkatakrishna Rajajee4. 1. Departments of Neurosurgery and Neurology, University of Michigan, 3552 Taubman Health Care Center; 1500 E. Medical Center Drive, SPC 5338, Ann Arbor, MI, 48109, USA. 2. Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, 3916 Taubman Center, SPC 5360, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109, USA. 3. Department of Neurosurgery, University of Michigan, 3552 Taubman Health Care Center; 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA. 4. Departments of Neurosurgery and Neurology, University of Michigan, 3552 Taubman Health Care Center; 1500 E. Medical Center Drive, SPC 5338, Ann Arbor, MI, 48109, USA. vrajajee@yahoo.com.
Abstract
BACKGROUND: Early detection of pulmonary edema is vital to appropriate fluid management following subarachnoid hemorrhage (SAH). Lung ultrasound (LUS) has been shown to accurately identify pulmonary edema in patients with acute respiratory failure (ARF). Our objective was to determine the accuracy of daily screening LUS for the detection of pulmonary edema following SAH. METHODS: Screening LUS was performed in conjunction with daily transcranial doppler for SAH patients within the delayed cerebral ischemia (DCI) risk period in our neuroICU. We reviewed records of SAH patients admitted 7/2012-5/2014 who underwent bilateral LUS on at least 5 consecutive days. Ultrasound videos were reviewed by an investigator blinded to the final diagnosis. "B+ lines" were defined as ≥3 B-lines on LUS. Two other investigators blinded to ultrasound results determined whether pulmonary edema with ARF (PE-ARF) was present during the period of evaluation on the basis of independent chart review, with a fourth investigator performing adjudication in the event of disagreement. The diagnostic accuracy of B+ lines for the detection of PE-ARF and RPE was determined. RESULTS: Of 59 patients meeting criteria for inclusion, 21 (36%) had PE-ARF and 26 (44%) had B+ lines. Kappa for inter-rater agreement was 0.821 (p < 0.0001) for clinical diagnosis of PE-ARF between the two investigators. B+ lines demonstrated sensitivity 90% (95% CI 70-99%) and specificity 82% (66-92%), for PE-ARF. Median days from B+ lines onset to PE-ARF was 1 (IQR 0-1). CONCLUSION: Screening LUS was a sensitive test for the detection of symptomatic pulmonary edema following SAH and may assist with fluid titration during the risk period for DCI.
BACKGROUND: Early detection of pulmonary edema is vital to appropriate fluid management following subarachnoid hemorrhage (SAH). Lung ultrasound (LUS) has been shown to accurately identify pulmonary edema in patients with acute respiratory failure (ARF). Our objective was to determine the accuracy of daily screening LUS for the detection of pulmonary edema following SAH. METHODS: Screening LUS was performed in conjunction with daily transcranial doppler for SAHpatients within the delayed cerebral ischemia (DCI) risk period in our neuroICU. We reviewed records of SAHpatients admitted 7/2012-5/2014 who underwent bilateral LUS on at least 5 consecutive days. Ultrasound videos were reviewed by an investigator blinded to the final diagnosis. "B+ lines" were defined as ≥3 B-lines on LUS. Two other investigators blinded to ultrasound results determined whether pulmonary edema with ARF (PE-ARF) was present during the period of evaluation on the basis of independent chart review, with a fourth investigator performing adjudication in the event of disagreement. The diagnostic accuracy of B+ lines for the detection of PE-ARF and RPE was determined. RESULTS: Of 59 patients meeting criteria for inclusion, 21 (36%) had PE-ARF and 26 (44%) had B+ lines. Kappa for inter-rater agreement was 0.821 (p < 0.0001) for clinical diagnosis of PE-ARF between the two investigators. B+ lines demonstrated sensitivity 90% (95% CI 70-99%) and specificity 82% (66-92%), for PE-ARF. Median days from B+ lines onset to PE-ARF was 1 (IQR 0-1). CONCLUSION: Screening LUS was a sensitive test for the detection of symptomatic pulmonary edema following SAH and may assist with fluid titration during the risk period for DCI.
Authors: Kenton L Anderson; J Matthew Fields; Nova L Panebianco; Katherine Y Jenq; Jennifer Marin; Anthony J Dean Journal: J Ultrasound Med Date: 2013-01 Impact factor: 2.153
Authors: Giacomo Baldi; Luna Gargani; Antonio Abramo; Luigia D'Errico; Davide Caramella; Eugenio Picano; Francesco Giunta; Francesco Forfori Journal: Intensive Care Med Date: 2012-09-28 Impact factor: 17.440
Authors: Jonathan A Friedman; Mark A Pichelmann; David G Piepgras; Jon I McIver; L Gerard Toussaint; Robyn L McClelland; Douglas A Nichols; Fredric B Meyer; John L D Atkinson; Eelco F M Wijdicks Journal: Neurosurgery Date: 2003-05 Impact factor: 4.654
Authors: Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer Journal: Crit Care Med Date: 2006-03 Impact factor: 7.598
Authors: N J Solenski; E C Haley; N F Kassell; G Kongable; T Germanson; L Truskowski; J C Torner Journal: Crit Care Med Date: 1995-06 Impact factor: 7.598
Authors: Ivan David Lozada-Martínez; María Manuela Rodríguez-Gutiérrez; Jenny Ospina-Rios; Michael Gregorio Ortega-Sierra; Mauro Antonio González-Herazo; Lina Marcela Ortiz-Roncallo; Rafael Martínez-Imbett; Andrés Elías Llamas-Nieves; Tariq Janjua; Luis Rafael Moscote-Salazar Journal: Egypt J Neurosurg Date: 2021-11-15